4400 Route 9 South
Suite 1000
Freehold, NJ 07728
United States
877 265 8266
https://www.chromocell.com
Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 4
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Francis Knuettel II, M.B.A. | CEO, CFO, Treasurer & Secretary | 107,5k | S.O. | 1966 |
Dr. Eric Lang M.D. | Chief Medical Officer | 264,99k | S.O. | 1963 |
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
L’ISS Governance QualityScore de Chromocell Therapeutics Corporation en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..